Phylogenetic analysis of the emergence of main hepatitis C virus subtypes in Sao Paulo, Brazil

Imagem de Miniatura
Arquivos
art_NISHIYA_Phylogenetic_analysis_of_the_emergence_of_main_hepatitis_2015.PDF (1.03 MB)
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2015
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
NISHIYA, Anna Shoko
FERREIRA, Suzete Cleusa
DI-LORENZO-OLIVEIRA, Claudia
SALLES, Nanci Alves
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.19, n.5, p.473-478, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: It is recognized that hepatitis C virus subtypes (1a, 1b, 2a, 2b, 2c and 3a) originated in Africa and Asia and spread worldwide exponentially during the Second World War (1940) through the transfusion of contaminated blood products, invasive medical and dental procedures, and intravenous drug use. The entry of hepatitis C virus subtypes into different regions occurred at distinct times, presenting exponential growth rates of larger or smaller spread. Our study estimated the growth and spread of the most prevalent subtypes currently circulating in Sao Paulo. Methods: A total of 465 non-structural region 5B sequences of hepatitis C virus covering a 14-year time-span were used to reconstruct the population history and estimate the population dynamics and Time to Most Recent Common Ancestor of genotypes using the Bayesian Markov Chain Monte Carlo approach implemented in BEAST (Bayesian evolutionary analysis by sampling tree software/program). Results: Evolutionary analysis demonstrated that the different hepatitis C virus subtypes had distinct growth patterns. The introduction of hepatitis C virus-la and -3a were estimated to be circa 1979 and 1967, respectively, whereas hepatitis C virus-1b appears to have a more ancient entry, circa 1923. Hepatitis C virus-1b phylogenies suggest that different lineages circulate in Sao Paulo, and four well-supported groups (i.e., G1, G2, G3 and G4) were identified. Hepatitis C virus-la presented the highest growth rate (r=0.4), but its spread became less marked after the 2000s. Hepatitis C virus-3a grew exponentially until the 1990s and had an intermediate growth rate (r=0.32). An evident exponential growth (r=0.26) was found for hepatitis C virus-1b between 1980 and the mid-1990s. Conclusions: After an initial period of exponential growth, the expansion of the three main subtypes began to decrease. Hepatitis C virus-1b presented inflated genetic diversity, and its transmission may have been sustained by different generations and transmission routes other than blood transfusion. Hepatitis C virus-1a and -3a showed no group stratification, most likely due to their recent entry.
Palavras-chave
Growth rate, HCV, Phylogenetic analysis, Subtypes
URI
https://observatorio.fm.usp.br/handle/OPI/12391
Referências
  1. Lampe E, 2010, INFECT GENET EVOL, V10, P886, DOI 10.1016/j.meegid.2010.05.010
  2. Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0
  3. Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P279
  4. Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009
  5. Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808
  6. Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
  7. Levi JE, 2002, J CLIN MICROBIOL, V40, P2645, DOI 10.1128/JCM.40.7.2645-2647.2002
  8. Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
  9. Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606
  10. Valente VB, 2005, REV SOC BRAS MED TRO, V38, P488, DOI 10.1590/S0037-86822005000600008
  11. Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4
  12. SIMMONDS P, 1993, J GEN VIROL, V74, P661, DOI 10.1099/0022-1317-74-4-661
  13. Morice Y, 2006, J MED VIROL, V78, P1296, DOI 10.1002/jmv.20692
  14. Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0
  15. Jeannel D, 1998, J MED VIROL, V55, P92
  16. de Almeida-Neto C, 2013, TRANSFUSION, V53, P827, DOI 10.1111/j.1537-2995.2012.03840.x
  17. Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182
  18. Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003
  19. Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959
  20. Noronha IL, 1997, NEPHROL DIAL TRANSPL, V12, P2234, DOI 10.1093/ndt/12.11.2234
  21. Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1
  22. Smith DB, 1997, J GASTROEN HEPATOL, V12, P522, DOI 10.1111/j.1440-1746.1997.tb00477.x
  23. Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014
  24. DONAHUE JG, 1992, NEW ENGL J MED, V327, P369, DOI 10.1056/NEJM199208063270601
  25. Nascimento MC, 2008, J MED VIROL, V80, P53, DOI 10.1002/jmv.21046
  26. MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493
  27. Silva MBS, 2010, MEM I OSWALDO CRUZ, V105, P299, DOI 10.1590/S0074-02762010000300009
  28. Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c
  29. Zarife MAS, 2006, T ROY SOC TROP MED H, V100, P663, DOI 10.1016/j.trstmh.2005.09.009
  30. Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321
  31. Bastos FI, 2009, J CLIN VIROL, V44, P200
  32. Brandão Ajacio B M, 2002, BMC Gastroenterol, V2, P18, DOI 10.1186/1471-230X-2-18
  33. CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
  34. Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
  35. Focaccia R, 1998, BRAZ J INFECT DIS, V2, P269
  36. Junqueira Pedro C., 2005, Rev. Bras. Hematol. Hemoter., V27, P201, DOI 10.1590/S1516-84842005000300013
  37. Lopes Carmen L R, 2009, Rev Saude Publica, V43 Suppl 1, P43, DOI 10.1590/S0034-89102009000800008
  38. Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198
  39. Mendes-Correa Maria Cassia J., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P15, DOI 10.1590/S0036-46652001000100003
  40. Nishiya AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086413
  41. Oliveira Maria de Lourdes Aguiar, 2006, Cad Saude Publica, V22, P861, DOI 10.1590/S0102-311X2006000400024
  42. Pereira LM, 2009, BMC INFECT DIS, V13, P60
  43. Pybus Oliver G., 2005, Infection Genetics and Evolution, V5, P131, DOI 10.1016/j.meegid.2004.08.001
  44. Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170
  45. Rosini Nilton, 2003, Braz J Infect Dis, V7, P262, DOI 10.1590/S1413-86702003000400006
  46. Salles Nanci A, 2003, Rev Panam Salud Publica, V13, P111, DOI 10.1590/S1020-49892003000200011
  47. Simmonds P, 2013, CURR TOP MICROBIOL, V369, P1, DOI 10.1007/978-3-642-27340-7_1
  48. WHO, 1999, J VIRAL HEPATITUS, V6, P35
  49. WHO, 2012, HEP C N 164 FS, V2014
  50. Wolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/46
Carregar mais